A tumor surveillance model: A non-coding RNA senses neoplastic cells and its protein partner signals cell death

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 13134-13139

  Jeon, Sung Ho ^a   Johnson, Betty H ^b   Lee, Yong Sun ^b  

^a Hallym University   (South Korea)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Nc886; Non coding rna; Pkr (protein kinase r); Surveillance; Tumor

Indexed keywords

GENOMIC DNA; NC886; PROTEIN KINASE R; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CELL DEATH; DNA REPAIR; EPIGENETICS; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPLICATION; GENOME ANALYSIS; HUMAN; IMMUNOSURVEILLANCE; MOLECULAR DYNAMICS; MUTATION RATE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL; BIOLOGICAL MODEL; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; EIF-2 KINASE; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; RNA, UNTRANSLATED;

EID: 84867805449     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131013134     Document Type: Article

References (15)

1. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011, 61, 212-236.
2. Vogelstein, B.; Kinzler, K.W. The multistep nature of cancer. Trends Genet. 1993, 9, 138-141.
3. Drake, J.W.; Charlesworth, B.; Charlesworth, D.; Crow, J.F. Rates of spontaneous mutation. Genetics 1998, 148, 1667-1686.
4. Malmberg, K.J.; Ljunggren, H.G. Escape from immune- and nonimmune-mediated tumor surveillance. Semin. Cancer Biol. 2006, 16, 16-31.
5. Klein, G.; Klein, E. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution. Proc. Natl. Acad. Sci. USA 1977, 74, 2121-2125.
6. Hoglund, P. DNA damage and tumor surveillance: One trigger for two pathways. Sci. STKE 2006, 2006, doi:10.1126/stke.3172006pe2.
7. Klein, G. Cancer, apoptosis, and nonimmune surveillance. Cell Death. Differ. 2004, 11, 13-17.
8. Lee, K.; Kunkeaw, N.; Jeon, S.H.; Lee, I.; Johnson, B.H.; Kang, G.Y.; Bang, J.Y.; Park, H.S.; Leelayuwat, C.; Lee, Y.S. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 2011, 17, 1076-1089.
9. Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice, A.; Kamphorst, A.O.; Landthaler, M., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129, 1401-1414.
10. Nandy, C.; Mrazek, J.; Stoiber, H.; Grasser, F.A.; Huttenhofer, A.; Polacek, N. Epstein-barr virus-induced expression of a novel human vault RNA. J. Mol. Biol. 2009, 388, 776-784.
11. Stadler, P.F.; Chen, J.J.; Hackermuller, J.; Hoffmann, S.; Horn, F.; Khaitovich, P.; Kretzschmar, A.K.; Mosig, A.; Prohaska, S.J.; Qi, X., et al. Evolution of vault RNAs. Mol. Biol. Evol. 2009, 26, 1975-1991.
12. Kunkeaw, N.; Jeon, S.H.; Lee, K.; Johnson, B.H.; Tanasanvimon, S.; Javle, M.; Pairojkul, C.; Chamgramol, Y.; Wongfieng, W.; Gong, B., et al. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene 2012, doi:10.1038/onc.2012.382.
13. Jeon, S.H.; Lee, K.; Lee, K.S.; Kunkeaw, N.; Johnson, B.H.; Holthauzen, L.M.; Gong, B.; Leelayuwat, C.; Lee, Y.S. Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett. 2012, 586, 3477-3484.
14. Garcia, M.A.; Meurs, E.F.; Esteban, M. The dsRNA protein kinase PKR: Virus and cell control. Biochimie 2007, 89, 799-811.
15. Treppendahl, M.B.; Qiu, X.; Sogaard, A.; Yang, X.; Nandrup-Bus, C.; Hother, C.; Andersen, M.K.; Kjeldsen, L.; Mollgaard, L.; Hellstrom-Lindberg, E., et al. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood 2012, 119, 206-216.